Validation of the Japanese Version of the Edmonton Symptom Assessment System–Revised

Yokomichi, Naosuke; Morita, Tatsuya; Nitto, Akihiro; Takahashi, Naoko; Miyamoto, Shingo; Nishie, Hiroyuki; Matsuoka, Junji; Sakurai, Hiromu; Ishihara, Teruo; Mori, Masanori; Tarumi, Yoko; Ogawa, Asao

doi:10.1016/j.jpainsymman.2015.05.014

Cited by 63 publications

(60 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is in accordance with a Japanese study where ESAS-r was significantly higher in patients with an ECOG performance status of 2-4 than in those with a performance status of 0 and 1 29 . Similarly, in the study done by Shalini et al, patients with lower performance status measured by both ECOG and Karnofsky performance scales had worse QoL scores in symptomatic pancreatic pain 30 .…”

Section: Discussionsupporting

confidence: 93%

The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer

El-Sayed

Elsawy

El-Azony

et al. 2017

Kasr-Al-Aini J.of Clin. Onc. and Nuc. Med.

View full text Add to dashboard Cite

Background: There is a relation between the severity of pain and common symptoms in patients with metastatic cancer. Aim: This study was done to explore this relation among Egyptian patients with advanced cancer. Methods: The study included 120 adult metastatic cancer patients with pain from two cancer centers in Cairo and Sharkia, Egypt. Pain and other common symptoms were assessed using the Arabic version of the Edmonton Symptom Assessment System (ESAS). The Eastern Cooperative Oncology Group (ECOG) performance scale was used to assess performance status. Results:The prevalence of ESAS symptoms was high among patients with cancer pain (tiredness, 94%; drowsiness, 63%; nausea, 60%; lack of appetite, 77%; shortness of breath, 53%; depression, 88%; anxiety, 83%; poor wellbeing, 96%). The ECOG performance scale was 1 in 21 (17.5%) patients, 2 in 57 (47.5%), 3 in 38 (31.7%) and 4 in 4 (3.3%). The average ESAS score was 33.9 ± 13.8, 48.9 ± 14.7, 58 ± 15.4 and 70 ± 5.5 among patients with ECOG score 1, 2, 3 and 4; respectively (p < 0.001). There was no significant difference in the average score of any of the ESAS items according to the site of metastases. There was a significant positive correlation between the pain score and the scores of tiredness (p<0.001), nausea (p=0.037), lack of appetite (p<0.001), shortness of breath (p=0.001), depression (p<0.001), anxiety (p<0.001) and poor wellbeing (p<0.001). Conclusion: Egyptian patients with cancer pain experience high symptom burden. The severity of pain strongly correlates with the presence and severity of other ESAS symptoms. Systematic assessment of other symptoms is indispensable in patients with cancer pain for proper control of symptoms and improving quality of life.

show abstract

Section: Discussionsupporting

confidence: 93%

The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer

El-Sayed

Elsawy

El-Azony

et al. 2017

Kasr-Al-Aini J.of Clin. Onc. and Nuc. Med.

View full text Add to dashboard Cite

show abstract

“…Congruent with our results, other researchers found a significant negative relationship between symptom burden and functional status of advanced cancer patients [27][28][29][30][31] . In a recent study from Egypt that included patients with metastatic cancer, the total average ESAS score differed significantly according to the Eastern Cooperative Oncology Group (ECOG) performance scale from 34 in patients with an ECOG score of 1 to 70 in patients with an ECOG score…”

Section: Discussioncontrasting

confidence: 51%

“…Similarly, in a study from Japan that included 292 cancer patients, the total ESAS-r score was significantly higher among patients with an ECOG score of 2-4 than those with a score of 0-1 (p<0.0001) 28 . In another study that included pancreatic cancer patients; pain, digestive symptoms, cachexia and ascites were significantly more likely to be reported by patients with an ECOG score of ≥1 29 .…”

Section: Esas Itemmentioning

confidence: 81%

The Relationship between Distressing Symptoms and Performance Status among Cancer Patients Receiving Palliative Care

Hussenein

Hashem

Hadary

et al. 2017

Kasr-Al-Aini J.of Clin. Onc. and Nuc. Med.

View full text Add to dashboard Cite

Background:Patients with advanced cancer experience distressing symptoms and progressive decline in their performance status (PS) as death approaches. Aim: To identify the relationship between symptom burden and PS of Egyptian cancer patients receiving palliative care. Methods: This was a prospective observational study that included 100 patients with advanced cancer. Symptom burden was assessed using the Arabic version of the revised Edmonton Symptom Assessment System (ESAS-r). Performance status was assessed using the Palliative Performance Scale (PPS). Results:The mean total ESAS-r score was 60.1 (±10.7). The most common symptom to be reported as severe was pain (93%) followed by tiredness (74%), poor wellbeing (67%), lack of appetite (62%), anxiety (60%) and drowsiness (56%). The majority of patients (76%) had a PPS score ≤30 with an overall mean PPS score of 36.2 (±13.3). There was a statistically significant negative correlation between the total ESAS score and the PPS score (r = -0.687, p = < 0.001). Conclusion:The results suggest that Egyptian patients with advanced cancer experience high symptom burden and significant decline in PS. The higher the symptom burden, the poorer the PS of patients with advanced cancer.

show abstract

“…19, 21, 29, 30, 57 Potential reasons that the correlation was only moderate and not strong may include differences in time frames analyzed by each scale and different question phrasing and content.…”

Section: Discussionmentioning

confidence: 99%

Could Objective Tests Be Used to Measure Fatigue in Patients With Advanced Cancer?

Schvartsman

Park

Liu

et al. 2017

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

Context Assessment of cancer-related fatigue is currently based on patient-reported outcomes. We asked whether objective assessments such as muscle strength and nutritional markers can be used as surrogate measures of cancer-related fatigue. Objective We examined the association among three fatigue scales, muscle strength, and nutritional markers in patients with advanced cancer. Methods In this prospective study, we enrolled hospitalized cancer patients who had been seen in palliative care consultation at MD Anderson Cancer Center. We assessed fatigue with use of three fatigue scales—the Brief Fatigue Inventory (BFI), the Edmonton Symptom Assessment System (ESAS), and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30)—and determined their association with objective assessments, including handgrip strength, maximal inspiratory pressure (MIP), lean body mass, phase angle, and albumin. Spearman’s correlation test was used to assess associations. Results Among 222 patients, the mean age was 55 years; 59% were female. The median overall survival was 106 days. The total BFI score had weak association with handgrip strength (ρ = −0.18, P = 0.007) and no association with the remaining objective measures. ESAS fatigue and EORTC fatigue showed similar findings. Total BFI had moderate to strong association with ESAS (ρ = 0.54, P < 0.0001) and EORTC (ρ = 0.60, P < 0.0001) fatigue. Conclusion Our study showed that subjective assessment of fatigue based on patient-reported outcomes correlates only weakly with muscle strength and nutritional markers; thus, patient-reported outcomes remain the gold standard for fatigue assessment.

show abstract

Validation of the Japanese Version of the Edmonton Symptom Assessment System–Revised

Abstract: The Japanese version of the ESAS-r is a reliable and valid tool for measuring symptoms in Japanese adult patients with cancer.

Cited by 63 publications

References 30 publications

The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer

The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer

The Relationship between Distressing Symptoms and Performance Status among Cancer Patients Receiving Palliative Care

Could Objective Tests Be Used to Measure Fatigue in Patients With Advanced Cancer?

Contact Info

Product

Resources

About